Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

October 30, 2023

Study Completion Date

June 28, 2025

Conditions
Nasopharyngeal CarcinomaImage-Guided Biopsy
Interventions
DIAGNOSTIC_TEST

Nasopharyngeal Endoscopy image-guided Biopsy

For each participant presenting with a suspicious nasopharyngeal lesion, the attending physician will assess the lesion and determine the appropriate biopsy approach. The physician may decide on multiple biopsies from the lesion area, including one sample from within the lesion itself, another from 5-8 mm outside the lesion, and a third from 8-10 mm beyond the lesion. Alternatively, a single biopsy may be deemed sufficient based on the clinical judgment. Each of these specimens will undergo pathological examination to confirm whether they are carcinomatous or non-carcinomatous.

Trial Locations (5)

350014

RECRUITING

Fujian Provincial Cancer Hospital, Fuzhou

510060

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

RECRUITING

Sun Yat-Sen University Cancer Center, Guangzhou

570311

RECRUITING

Hainan Provincial People's Hospital, Haikou

Sponsors
All Listed Sponsors
collaborator

Sun Yat-sen University

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Hainan People's Hospital

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT05202626 - Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images | Biotech Hunter | Biotech Hunter